Medical SaaS Provider LinkedCare Raises USD15.1 Mln in Series-B Funding to Enter International Markets
Liao Shumin
DATE:  Dec 08 2017
/ SOURCE:  Yicai
Medical SaaS Provider LinkedCare Raises USD15.1 Mln in Series-B Funding to Enter International Markets Medical SaaS Provider LinkedCare Raises USD15.1 Mln in Series-B Funding to Enter International Markets

(Yicai Global) Dec. 8 -- Medical 'Software as a service' (SaaS) provider Shanghai LinkedCare Information Technology Co. completed its series-B funding of CNY100 million (USD15.1 million) led by a holding subsidiary of Shanghai Fosun Pharmaceutical (Group) Co. [HKG:2196], online media outlet Jiemian.com reported. The funds raised will help the company start its internationalization strategy, while expanding its consumable supply chain, the firm said.

LinkedCare will also use the funds to increase investment in product and service innovation. Positioned as an information service provider in the field of medical consumption, LinkedCare is focusing on providing e-dental and e-aesthetic medical intelligent management system for oral and aesthetic medicine institutions.

Since entering the oral industry in 2015, LinkedCare has now covered nearly 10,000 middle and high-end dental clinics, it says. The company witnessed strong demand prompted by the rapid development of aesthetic medicine industry in the past two years, thus accelerating its layout in aesthetic medical SaaS, said Li Feng, co-founder of the firm. LinkedCare officially introduced its latest aesthetic medical SaaS intelligent management system last April.

As for business model, LinkedCare charges fees for software sales and services through SaaS platform while exploring the connection and synergy between oral equipment consumption and supply chain and e-dental SaaS system to benefit from the supply chain. E-dental procurement platform for enterprises has already provided superior commodities of over 3,000 SKU, helping oral institutions gain a cost advantage of supply chain while improving the efficiency of procurement and inventory management of oral institutions at the same time, it says.

LinkedCare completed angel financing led by Matrix Partners China in August 2015, closed series-A funding led by DXY and joined by Matrix Partners China in January 2016, and raised money in series-A+ funding joined by Fosun Tonghao Capital, a subsidiary of Fosun Group in August 2016.

Follow Yicai Global on
Keywords:   LinkedCare,Beauty Clinic,Shanghai Fosun Pharmaceutical Group